EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.22.52 | medicine | calpain and calpain inhibition is a therapeutic tool in Parkinsons disease | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.22.52 | MDL-28710 | complete inhibition at 100 nM | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.4.22.52 | mitochondrion | - |
Homo sapiens | 5739 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.4.22.52 | Ca2+ | dependent on, dysfunctional mitochondria increase cytosolic calcium, thereby inducing calpain activation | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.22.52 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.22.52 | NT2-Rho0 cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.22.52 | acetyl-LLY-7-amido-4-fluoromethylcoumarin + H2O | - |
Homo sapiens | acetyl-LLY + 7-amino-4-fluoromethylcoumarin | - |
? | |
3.4.22.52 | alpha-synuclein + H2O | - |
Homo sapiens | 145000 DA fragment + 150 Da fragment + ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.22.52 | calpain 1 | - |
Homo sapiens |
EC Number | Organism | Comment | Expression |
---|---|---|---|
3.4.22.52 | Homo sapiens | compared to control cybrids, Parkonsins disease cybrids reveal a significant increase in calpain activity | up |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.4.22.52 | malfunction | calpain-1 overactivation in mitochondrial-deficient cells promotes caspase-3 activation, calpain inhibition decreases alpha-synuclein oligomerization | Homo sapiens |